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Abstract In the rat, the sexual dimorphism in growth hor-
mone release is driven by sex steroids, and is suggested to
result mainly from diVerences in somatostatin (SOM)
release patterns from the median eminence. We studied the
eVect of gonadal steroids on SOM peptide-containing cells
in the periventricular nucleus (PeVN) of ovariectomized
(OVX) female rats, and compared these data with data from
intact male rats. Adult female rats were treated with estra-
diol (E2) and/or progesterone (P), 3 months (long-term) or
2 weeks (short-term) after ovariectomy (OVX). Perfusion-
Wxed brains were sliced and stained, and the number of
SOM-immunoreactive (-ir) cells and total SOM-ir area (in
m2) were determined using computer assisted analysis.
SOM-ir cells in the PeVN showed a very characteristic
rostro-caudal distribution and localization in relation to the
third ventricle. Both the number of SOM-ir cells and total
SOM-ir area in the PeVN were higher in male compared to
OVX female rats. Neither the number of SOM-ir cells, nor
the total SOM-ir area in the PeVN was aVected by E2 or P
treatment alone. Treatment with both gonadal steroids,
however, did increase total SOM-immunoreactivity. This
study is the Wrst to describe SOM cell distribution within
the rat PeVN in great detail. A clear sex diVerence exists in
SOM peptide content in the rat PeVN. In addition, E2 and P
may act synergistically to aVect SOM cells in the female
PeVN, suggesting that both gonadal steroids may be
involved in the generation of the typical feminine SOM
release pattern.
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Introduction
In the rat, growth hormone (GH) release patterns are sexu-
ally dimorphic (Clark et al. 1987; Eden 1979; Gatford et al.
1998). In males, GH secretion is characterized by regular
high amplitude pulses occurring at approximately 3-h inter-
vals, and low baseline levels. Females exhibit irregular low
amplitude GH levels and higher baseline levels than males
(Clark et al. 1987; Eden 1979; Gatford et al. 1998).
Release of GH from the pituitary is mainly regulated by
the interplay between the stimulating eVects of GH-releas-
ing hormone (GHRH), synthesized in cells of the arcuate
nucleus of the hypothalamus (ARC), and the inhibiting
eVects of somatostatin (SOM), synthesized in cells of the
periventricular nucleus of the hypothalamus (PeVN)
(Critchlow et al. 1981; Gillies 1997; Katakami et al. 1988;
Praputpittaya et al. 1987; Tannenbaum and Ling 1984;
Tannenbaum et al. 1990; Terry and Martin 1981; Urman
et al. 1985; Zeitler et al. 1991). Also ghrelin is found to
stimulate GH release and ghrelin-producing cells in the
hypothalamus may stimulate GHRH cells in the ARC
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as well as the impact of ghrelin in the hypothalamic regula-
tion of GH secretion remains uncertain.
The typical masculine and feminine GH secretion pat-
terns are most likely the direct result of diVerences in SOM
and GHRH release patterns between the sexes. In male rats,
SOM is released in regular pulses with maximal levels dur-
ing a GH trough and minimal levels during a GH peak
(Kasting et al. 1981; Plotsky and Vale 1985; Tannenbaum
and Ling 1984; Tannenbaum et al. 1990, 1993; Zeitler et al.
1991). In females, SOM release is thought to be more con-
stant, and at a level in-between the maximum and minimum
levels that are observed in males (Clark and Robinson
1985; Painson and Tannenbaum 1991), although relatively
small and irregular SOM peaks have also been reported
(Estupina et al. 1996). GHRH release from the ME on the
other hand, appears to be pulsatile in both sexes, albeit reg-
ular in male rats, with peak levels occurring during the
SOM troughs, and irregular in females (Clark and Robin-
son 1985; Jansson et al. 1985; Painson and Tannenbaum
1991; Plotsky and Vale 1985; Tannenbaum and Ling 1984;
Tannenbaum et al. 1990; Zeitler et al. 1991). Thus, with
respect to the bimodal hypothalamic regulation of GH
release, diVerences in SOM release are most pronounced
between the sexes. Therefore, the sexual dimorphism in GH
release has been suggested to result mainly from diVerences
in SOM release patterns from the median eminence (ME)
(Gillies 1997; Muller et al. 1999; Tannenbaum et al. 1990).
As GH release patterns are highly dependent on the
gonadal steroidal milieu (Jansson et al. 1984; Jansson and
Frohman 1987a; b), the synthesis and release of SOM may
also be aVected by gonadal steroids. Indeed, castration of
male rats decreases both hypothalamic SOM mRNA levels
and SOM peptide content, which can be restored by treat-
ment with testosterone (Bethea et al. 1992; Chowen-Breed
et al. 1989; Murray et al. 1999; Werner et al. 1988; Zorilla
et al. 1991). In female rats, estradiol (E2) aVects both hypo-
thalamic SOM mRNA and peptide levels, although con-
Xicting results have been reported: Neither ovariectomy
(Murray et al. 1999), nor E2 treatment of ovariectomized
(OVX) rats (Estupina et al. 1996) aVects the total hypotha-
lamic SOM peptide content. In contrast, SOM mRNA lev-
els in the PeVN also decrease following OVX, but this
reduction can be reversed by treatment with E2 (Bethea
et al. 1992; Werner et al. 1988; Zorilla et al. 1990). In addi-
tion, it is reported that in the cycling female rat hypotha-
lamic SOM content and SOM release from the ME
Xuctuate concurrently with plasma E2 levels during the
estrous cycle (Estupina et al. 1996; Freeman 1994; Knuth
et al. 1983; Zorilla et al. 1991). This suggests that E2 may
indeed aVect hypothalamic SOM synthesis and release. The
precise role of E2 in the regulation of hypothalamic SOM
system activity in the female rat remains to be established.
Also progesterone (P), which has a direct feedback action at
the brain level to control the female reproductive cycle
(Freeman 1994), may be involved in the regulation of the
typical feminine SOM release pattern. To date, the role of
progesterone in the hypothalamic regulation of GH release
has not been studied at all.
In the present study, we Wrst compared the distribution
of SOM cells within the PeVN between adult OVX female
and male rats in detail. In addition, we examined the eVects
of gonadal steroids on the number of SOM cells and on
SOM peptide content in the PeVN of female rats.
Methods
Animals
A total of 46 Wistar rats (8 adult males and 38 adult
females) (Harlan, Horst, The Netherlands) were pair-
housed in a room with controlled lighting (12L:12D, lights
on at 04.00 h), temperature (23°C), and humidity (70%).
Standard pelleted food and tap water were available ad libi-
tum. A dim red light remained on at all times, including the
dark period. Males were 4 months old and females were
11–12 weeks (group I, n = 32) or 16 weeks (group II, n = 6)
old on arrival. All experiments were carried out in accor-
dance with the “Principles of laboratory animal care” of
the NIH and the Wageningen University Animal Ethics
Committee approved all experiments.
Experimental design
All female rats underwent bilateral ovariectomy (OVX) at
12 weeks of age (group I) or at the age of 18 weeks (group
II) under gas anesthesia with a mixture of IsoXurane (IsoXo;
Abbott Laboratories Ltd, England) and oxygen (3:1 ratio).
Three months (3 mo) after OVX, the females of group I
(“long-term”) received a subcutaneous (s.c.) injection with
estradiol benzoate (EB; 12.5 g/0.1 ml cottonseed oil;
n = 16) or with 0.1 ml cottonseed oil only (n = 16) between
08:30 and 09:00 h on two consecutive days (treatment day
1 and 2). On day 3, the rats received an s.c. injection with
either progesterone (P; 0.25 mg/0.1 ml cottonseed oil)
(“OVX + P”, n = 8 and “OVX + E2 + P”, n = 8) or with
0.1 ml cottonseed oil only (“OVX”, n = 8 and “OVX + E2”,
n = 8) at 11:00 h.
As results obtained from previous studies in our lab sug-
gested that the time period of steroid deprivation following
OVX may change the sensitivity of SOM cells to E2 feed-
back (unpublished data), an additional group of OVX
females was included (group II, “short-term”) to compare
the eVects of EB treatment between short-term and long-
term OVX animals on hypothalamic SOM peptide levels.123
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tions with EB (treatment day 1 and 2) and an s.c. injection
with oil (treatment day 3), 2 weeks after OVX.
On treatment day 3, all female and male rats were per-
fused just prior to dark onset, i.e. between 15:30 and
16:00 h. Prior to perfusion, animals were given an overdose
of Nembutal® anesthesia (CEVA sante animale B·V.,
Maassluis, The Netherlands; 1.5 ml/kg body weight; i.p.).
Rats were perfused transcardially with 200 ml (females) or
300 ml (males) saline followed by 300 ml (females) or
400 ml (males) Somogyi Wxative (2% paraformaldehyde in
0.1 M phosphate buVer pH 7.4 with 0.1% glutaraldehyde
and 0.2% saturated picric acid) (Somogyi and Takagi
1982). Brains were removed from the skull immediately
after perfusion and post-Wxed in the same Wxative for 25 h
at 4°C. Tissue blocks containing the hypothalamus were
sliced into coronal sections of 40 m using a Vibratome
(Vibratome Company, St Louis, USA; series 1500), distrib-
uted into three series of alternating sections and stored in
0.1 M Tris buVer containing 0.9% NaCl (TBS, pH 7.4) at
4°C until immunocytochemistry.
Immunocytochemistry
One series of sections (one-third of the total hypothalamus)
of each animal was stained for SOM peptide using free-
Xoating immunocytochemistry techniques (Van der Beek
et al. 1994). Sections were pretreated with 3% H2O2
(Merck, Darmstadt, Germany) in TBS for 30 min, followed
by extensive washing with TBS. Subsequently, sections
were incubated with the primary polyclonal rabbit antibody
raised against SOM peptide (Somaar 080289, NIH,
Amsterdam, The Netherlands; Wnal dilution 1:30,000)
(Buijs et al. 1989), diluted in supermix (TBS containing
0.5% Triton-X-100 and 0.25% gelatin) for one night at 4°C.
This was followed by incubation with biotinylated goat
anti-rabbit Immunoglobulin G (GaR-bio; Vector Laborato-
ries; Burlingame, CA; USA, 1:500 in supermix) for 1.5 h at
room temperature, and Avidin-Biotin Complex-elite (ABC;
Vector Laboratories; Wnal dilution 1:1,500 in supermix) for
1.5 h at room temperature. Between incubation steps, sec-
tions were thoroughly washed with TBS. Immunoreactivity
for SOM was visualized by incubation with 0.05% 3,3-
diaminobenzidine (DAB; Sigma Chemical Company, St
Louis, MO, USA) in TBS containing 0.1% imidazole and
0.03% H2O2 for 14.5 min.
Stained sections were mounted on albumin-coated
slides, dried, dehydrated and coverslipped in DEPEX
(BDH Laboratory Supplies, Poole, England). SOM-immu-
noreactive (SOM-ir) neurons in the PeVN were counted
using computer assisted image analysis (Scion Image Beta,
version 4.02; Scion Corporation, Maryland, USA) follow-
ing background correction (Bethea et al. 1992).
Selection of the PeVN area
Images of the left side of the brain containing the PeVN
(standardized to 9 images per rat brain) were captured using
a microscope (50x magniWcation) with a digital black-and-
white CCD camera (Sony, XC-77CE) connected to a com-
puter. The nine consecutive sections (80 m apart) contain-
ing the PeVN were selected using several criteria, including
the shape of the third ventricle and the optic chiasm as well
as the staining pattern. The Wrst section of the PeVN
included for analysis was the section in which the suprach-
iasmatic nucleus (SCN) Wrst appeared (Plate 22 according
to Paxinos and Watson (Paxinos and Watson 1986). The
last section of the PeVN included for analysis was the last
section before the ventral medial nucleus (VMN), contain-
ing dense SOM Wber staining, Wrst appeared (Plate 26 Paxi-
nos and Watson 1986). The total PeVN, deWned as
described above includes all periventricular SOM cells that
have been shown to project to the ME (Ishikawa et al.
1987; Merchenthaler et al. 1989). In line with previous
reports (Argente et al. 1990; Epelbaum et al. 1986; Wil-
loughby et al. 1989) and for evaluation purposes only, the
total length of the PeVN was divided into three rostro-to-
caudal subregions: the anterior, medial, and posterior
PeVN, referring to respectively PeVN sections 1–3, 4–6
and 7–9.
For schematic camera lucida drawings of the PeVN,
images were imported into Adobe Illustrator (version 8.0),
a drawing program in which schematic drawings can be
made by placing an empty layer over the image Wle. In this
layer, immunoreactive neurons were marked and saved.
Data analysis
Images of the left side of the brain containing the PeVN,
covering the 9 consecutive PeVN sections as described
above, were captured using a microscope (100£ magniWca-
tion) with a digital black-and-white CCD camera (Sony,
XC-77CE) connected to a computer. Unilateral analysis
was performed since no signiWcant diVerences in SOM-
immunoreactivity (-ir) and cell number within the PeVN
were detected between the left and right side of the hypo-
thalamus (unpublished results). Images were analyzed
using an image analysis program (Scion Image Beta, ver-
sion 4.02; Scion Corporation, Maryland, USA) applying
gray level threshold discrimination (Bethea et al. 1992). By
capturing each image at the same gray level, i.e. the aver-
age gray level of the entire image, a background correction
was made. Subsequently, the gray level was used to deter-
mine the threshold for analysis by measuring true back-
ground (i.e. the gray level in an area that contained SOM-ir
Wbers, but no SOM-ir cell bodies) in a representative selec-
tion of all images. The threshold was calculated based on123
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tion, thus reducing the chance of false positive cell counts
to P < 0.01. Using this threshold, the number of SOM-ir
neurons was counted automatically. A cutoV size of
5 pixels (16.2 m2) was used as a lower limit; excluding the
possibility of including dendrites in the automated cell
count (see Fig. 1). 
The mean average number of neurons per section as well
as the mean cumulative number of cells per animal (i.e.
total SOM number of nine PeVN sections) was calculated
for each group (mean § SEM). In addition to cell counts,
we also analyzed the total area (in m2) covered by SOM-
immunoreactivity above threshold level using the same
images and analysis program as described above. This mea-
surement provides a reliable tool to estimate the amount of
SOM peptide present in the PeVN and is independent of
cell size. In general, SOM cell number and SOM-ir mea-
surements showed a signiWcant and very high correlation
within individual animals in all groups, both males and
females (data not shown).
For statistical analysis, the total number of SOM-ir cells
and total SOM-ir area, i.e. the sum of nine PeVN sections
(“total PeVN”), were used. In addition to this, we analyzed
the number of SOM-ir cells and SOM-ir area in the ante-
rior, medial, and caudal part of the PeVN.
Data were analyzed using the SPSS statistical analysis
system (SPSS, Chicago, IL, USA). Oneway ANOVAs
were used to compare both the total number of SOM-ir
cells and total SOM-ir area (total PeVN and PeVN sub
regions) between the male group and all female groups,
and between the diVerent gonadal steroid treatments
within OVX female groups. In addition, separate Bonfer-
roni Tests were used for post-hoc testing to compare both
the number of SOM-ir cells and SOM-ir area between
diVerent gonadal steroid treatments in OVX females. To
compare the eVect of short-term versus long-term ovariec-
tomy on the number of SOM-ir cells and SOM-ir area
(total PeVN and PeVN sub regions), separate T-tests were
used. DiVerences were considered to be signiWcant when
P < 0.05.
Results
Rostro-caudal distribution of SOM cells within the PeVN
SOM immunoreactivity was found in cell bodies and Wbers
dispersed within a small zone just alongside the third ven-
tricle in both males and females, as previously described
(Ishikawa et al. 1987). Most cells within this region were
darkly stained large neurons, frequently showing more
than one immunoreactive dendrite extending from the cell
body. Immunoreactivity within the cell was localized in
the cytoplasm, resulting in a lighter stained central zone in
the cell soma representing the unstained nuclear region
(Fig. 2)
The rostral-caudal distribution of SOM-immunoreactive
(-ir) cells within the PeVN was comparable between the
sexes and showed a characteristic localization and distribu-
tion pattern in relation to the third ventricle (Figs. 3, 4). In
Fig. 1 Automated image analysis of SOM cells in the PeVN. Densito-
metric analysis of SOM-ir cells in the PeVN using a deWned threshold
level (see text for details). Pictures of the whole PeVN were taken from
sections deWned as PeVN level 5 from one representative OVX + E2
(a) and one representative male animal (c) (£100 magniWcation). In b
(OVX + E2) and d (male) all staining intensity above the deWned
threshold level is shown in black (using the automated image analysis
system). Only black dots larger than 5 pixels (i.e. 16.2 m2) were con-
sidered as a positively stained cell by the image analysis system (mea-
suring results not shown)123
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population of SOM-ir cells was located just above the sup-
rachiasmatic nucleus (SCN), directly lined along the ventri-
cle wall. Moving more caudally towards the medial part of
the PeVN (sections 4–6), a dense population of SOM-ir
cells covered the whole length of the third ventricle side
area, with maximum numbers of SOM-ir cells at the mid-
level (from ventral to dorsal) of the ventricle. Finally, in the
posterior part of the PeVN (sections 7–9) small populations
of SOM-ir cells were located for the most part along the
mid- and dorsal part of the ventricle wall (Fig. 3).
The total SOM-ir cell number was consistently higher in
male compared to ovariectomized (OVX) female rats
throughout the PeVN (Fig. 4). The rostro-caudal distribution
within the PeVN appeared to be slightly diVerent between
the sexes, i.e. maximal SOM-ir cell numbers were found in
section 7 in males, but consistently in section 6 in the OVX
females, irrespective of gonadal steroid treatment (Fig. 4).
Although in general the rostro-caudal distribution of
SOM-ir cells was comparable between diVerent steroid
treatment groups, the number of SOM-ir cells appeared to
diVer between steroid treatments in speciWc PeVN subre-
gions. E2 or P treatment alone led to a decrease in the num-
ber of SOM-ir cells mainly in the anterior and medial parts
of the PeVN compared to the untreated OVX females,
whereas the combined treatment with E2 and P increased
the number of SOM-ir cells particularly in the medial and
posterior parts of the PeVN compared to OVX, even
though not signiWcantly (Fig. 4).
EVect of sex and gonadal steroids on SOM cells 
and SOM-ir area in the PeVN
Both the total number of SOM-ir cells and the SOM-ir area
(i.e. above-threshold SOM peptide “presence”) in the
PeVN was signiWcantly higher in males compared to all
OVX female groups, irrespective of gonadal steroid treat-
ment (Fig. 5a, b).
E2 or P treatment alone aVected neither the total number
of SOM-ir cells nor the total SOM-ir area in the PeVN
(Fig. 5a, b). Treatment with both E2 and P increased the
SOM-ir area, but only signiWcantly when compared to treat-
ment with P alone (Fig. 5b). This eVect of combined E2 and
P on the number of SOM-ir cells and on the SOM-ir area
was most pronounced in the medial and posterior parts of
the PeVN, although the diVerences in each sub-region did
not reach statistical signiWcance (data not shown).
EVect of OVX length on SOM cells in the PeVN 
of E2-treated rats
The total number of SOM-ir cells in the PeVN was signiW-
cantly lower in long-term (3 months) compared with short-
term (2 weeks) ovariectomized females after E2-treatment
(Fig. 6; insert). This diVerence in SOM-ir cell number
between long-term and short-term OVX was signiWcant in
the anterior and medial, but not in the caudal PeVN (Fig. 6).
In contrast, total SOM-ir area in the PeVN did not diVer
between long-term and short-term OVX (36,235 §
6,531 m2 for short-term and 23,207 § 3,582 m2 for long-
term OVX, respectively), whereas OVX length signiW-
cantly decreased SOM-ir area in the anterior PeVN
(5,628 § 810 m2 for short-term and 2,467 § 368 m2 for
long-term OVX, respectively).
Discussion
The distribution of SOM cells within the male and female
rat PeVN has not been described in great detail previously.
Our study clearly shows a sex diVerence in the periventric-
ular SOM-ir cell distribution. The rostro-caudal distribution
being similar, both the relative total number of SOM-ir
cells and the SOM-ir area diVered markedly between the
sexes, with males having signiWcantly more SOM-ir cells
and a higher SOM-ir area than OVX females. In addition,
we show that in the female rat gonadal steroids modulate
SOM peptide immunoreactivity in the PeVN, and that the
number of SOM-ir cells is dependent on the period without
gonadal steroid hormones (as a result of ovariectomy).
The higher number of SOM-ir neurons in males com-
pared to females correlates with previous studies also
Fig. 2 SOM cells in the PeVN. 
Photographs showing SOM 
immunoreactivity in the PeVN 
of a representative male (a) and 
OVX + E2 female rat (b). Pic-
tures of the right side of the ven-
tricle were taken at a high 
magniWcation (£400) from sec-
tions deWned as PeVN level 5123
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1989; Muller et al. 1999) and a higher SOM peptide content
(Murray et al. 1999a, b; Nurhidayat et al. 2001) in the
PeVN of male compared to female rats.
In our study E2 treatment in OVX (3 mo.) female rats did
not have any eVect on periventricular SOM-ir area, which is
in line with Estupina et al. (1996) who also failed to
observe eVects of E2 on total hypothalamic SOM peptide
content in OVX rats. However, several other studies
showed that the eVects of OVX on SOM mRNA levels in
the PeVN could be reversed by E2 (Baldino et al. 1988;
Werner et al. 1988; Zorilla et al. 1990). These data strongly
indicate that the eVects of E2 on hypothalamic SOM cell
activity are controversial and may be diVerent with respect
to synthesis, peptide storage and/or release.
The role of P in the regulation of hypothalamic SOM
mRNA or peptide in the female rat has not been studied
before, as far as we know. Studies using rat anterior pituitary
cells show no eVects of P on SOM-suppressed GH release
(Fukata and Martin 1986), suggesting that P does not aVect
SOM receptor sensitivity or its expression on somatotrophs.
In the present study we found that treatment with the
Fig. 3 SOM cell distribution in 
the PeVN. Camera lucida draw-
ings of immunoreactive somato-
statin cells throughout the PeVN 
of the adult rat. Cell bodies at the 
left (female) and right (male) 
side of the third ventricle are 
indicated by open circles. These 
are drawings of the nine succes-
sive PeVN sections of one repre-
sentative OVX + E2 and one 
representative male rat. III third 
ventricle; o.c. optic chiasm; SCN 
suprachiasmatic nucleus
PeVN 2 PeVN 3 
III V 
SCN o.c.
F M
PeVN 1 
PeVN 4 PeVN 5 PeVN 6 
PeVN 7 PeVN 8 PeVN 9 123
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of SOM-ir cells and the SOM-ir area in the PeVN compared
to treatment with E2 (n.s.) or P (P < 0.05) alone, indicating
that P may indeed modulate the activity of the hypothalamic
SOM system in the female rat. This eVect was most pro-
nounced in the medial and posterior PeVN, suggesting that
these parts of the PeVN may be more sensitive to gonadal
steroids than the anterior part. These observations prompt
and support the suggestion of speciWc subsets of SOM neu-
rons within the PeVN with speciWc functions with regard to,
for instance, the regulation of GH secretion (Argente et al.
1990; Epelbaum et al. 1986; Willoughby et al. 1989).
Although the precise role of gonadal steroids in the regu-
lation of the activity of the periventricular SOM cells
remains unclear, SOM synthesis in the hypothalamus and
its release from the ME Xuctuate during the estrous cycle:
SOM mRNA in the PeVN was found to be minimal on the
day of diestrus and maximal on the day of proestrus (Zorilla
et al. 1991), when SOM peptide levels in the preoptic area,
posterior hypothalamus and ME were shown to be low
(Knuth et al. 1983). Yet, SOM release from the ME was
found to be maximal on the day of proestrus (Estupina et al.
1996), concurrent with cyclic elevations of plasma E2 and P
levels (Freeman 1994). These data suggest that E2 or P, and
more likely the combination of the two, aVects SOM syn-
thesis or release, or both, in the female rat. E2 and P may act
synergistically to aVect SOM peptide in the PeVN, and the
combination of both gonadal hormones may thus be essen-
tial for the generation of the typical feminine hypothalamic
SOM release pattern.
The eVects of E2 and P on periventricular SOM cells are
likely to be indirect. First, SOM neurons in the PeVN do not
contain E2-receptors  (ER) themselves (Herbison and
Theodosis 1993; Kamegai et al. 2001; Scanlan et al. 2003),
Fig. 4 Average number of SOM cells in the PeVN. Number of SOM-
ir cells in the nine successive PeVN sections of male (black bars),
OVX female (gray bars), OVX + E2 female (white bars), OVX + P
(light gray bars), and OVX + E2 + P female (dark gray bars) rats. Bars
represent means § SEM. N = 8 for each group. Overall testing re-
vealed signiWcant diVerences between male and female groups. SigniW-
cant (P < 0.05) post hoc testing results for individual sections are
indicated; males versus all female groups (asterisks) (PeVN
sections 1–3, 5–6, 8–9), males versus OVX + E2 and OVX + P (PeVN
section 4) (Hash), males versus OVX, OVX + E2, and OVX + P
(PeVN section 7) (circle), OVX versus OVX + E2 (PeVN section 4)
(cross)
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490 Exp Brain Res (2008) 188:483–491whereas ER expression was not found in the PeVN at all
(Kamegai et al. 2001; Simonian and Herbison 1997). E2
may therefore indirectly aVect SOM neurons in the PeVN
via SOM cells located in nearby hypothalamic areas that
contain ER (Herbison 1994), or via GABA-containing
neurons in the periventricular regions that have been shown
to be E2-receptive (Flugge et al. 1986) and were found to
project to SOM cells in the PeVN (Herbison and Augood
1994; Willoughby et al. 1987). Second, to our knowledge,
no data exist on the presence of the progesterone-receptor
(PR) in SOM cells in the hypothalamus. Although studies in
the guinea pig show that SOM cells do contain PR (Dufo-
urny and Warembourg 1996; Dufourny et al. 1998), no co-
localization was found in the PeVN, suggesting that also the
eVect of P on SOM cells in the PeVN is likely to be indirect.
We found that the number of SOM-ir cells in the PeVN
was also aVected by the time following ovariectomy. Total
SOM-ir cell numbers were signiWcantly lower in long-term
(3 months) compared to short-term (2 weeks) OVX females
that were treated with E2. We did not include a short-term
OVX group that was treated with vehicle for this study.
However, in a previous study in our lab we found no eVect
of E2 on the number of SOM-ir cells compared to vehicle-
treated animals after short-term OVX (unpublished results,
2001). These data suggest that the number of SOM-ir cells
in the female PeVN is also dependent on OVX length rather
than on E2 treatment alone. Hence, also P may indeed play
an essential role in the regulation of the periventricular
SOM system in the female rat.
The eVect of long-term OVX on SOM-ir cells was only
signiWcant in the anterior and medial parts of the PeVN,
whereas the eVects of gonadal steroids were most pro-
nounced in the medial and posterior PeVN. These data
again support the hypothesis for diVerent subsets of SOM
neurons within the PeVN with speciWc functions.
In conclusion, the present study indicates that SOM cell
distribution, number of SOM cells, and SOM peptide content
within the rat PeVN depend on gender and gonadal steroids.
Moreover, our data suggest that in the female rat E2 and P act
synergistically to aVect SOM cell activity in the PeVN.
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